title: Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.
abstract: Coreceptor switch from CCR5 to CXCR4 is associated with HIV disease progression. To document the evolution of coreceptor tropism during pregnancy, a longitudinal study of envelope gene sequences was performed in a group of pregnant women infected with HIV-1 of clade B (n=10) or non-B (n=9). Polymerase chain reaction (PCR) amplification of the V1-V3 region was performed on plasma viral RNA, followed by cloning and sequencing. Using geno2pheno and PSSMX4R5, the presence of X4 variants was predicted in nine of 19 subjects (X4 subjects) independent of HIV-1 clade. Six of nine X4 subjects exhibited CD4(+) T cell counts <200 cells/mm(3), and the presence of X4-capable virus was confirmed using a recombinant phenotypic assay in four of seven cases where testing was successful. In five of nine X4 subjects, a statistically significant decline in the geno2pheno false-positive rate was observed during the course of pregnancy, invariably accompanied by progressive increases in the PSSMX4R5 score, the net charge of V3, and the relative representation of X4 sequences. Evolution toward X4 tropism was also echoed in the primary structure of V2, as an accumulation of substitutions associated with CXCR4 tropism was seen in X4 subjects. Results from these experiments provide the first evidence of the ongoing evolution of coreceptor utilization from CCR5 to CXCR4 during pregnancy in a significant fraction of HIV-infected women. These results inform changes in host-pathogen interactions that lead to a directional shaping of viral populations and viral tropism during pregnancy, and provide insights into the biology of HIV transmission from mother to child.
authors.affiliation: 1 Unité d'immunopathologie virale, Centre de recherche du CHU Sainte-Justine , Montreal, Quebec, Canada .
authors.forename: Doris G
authors.initials: DG
authors.lastname: Ransy
authors.forename: Alena
authors.initials: A
authors.lastname: Motorina
authors.forename: Natacha
authors.initials: N
authors.lastname: Merindol
authors.forename: Bertine S
authors.initials: BS
authors.lastname: Akouamba
authors.forename: Johanne
authors.initials: J
authors.lastname: Samson
authors.forename: Yolanda
authors.initials: Y
authors.lastname: Lie
authors.forename: Laura A
authors.initials: LA
authors.lastname: Napolitano
authors.forename: Normand
authors.initials: N
authors.lastname: Lapointe
authors.forename: Marc
authors.initials: M
authors.lastname: Boucher
authors.forename: Hugo
authors.initials: H
authors.lastname: Soudeyns
mesh_terms: D000328:Adult; D018450:Disease Progression; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000821:virology*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D054884:Host-Pathogen Interactions; D006801:Humans; D008137:Longitudinal Studies; D008969:Molecular Sequence Data; D010949:Plasma / Q000821:virology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000821:virology*; D012367:RNA, Viral / Q000235:genetics; D015728:Receptors, HIV / Q000378:metabolism*; D017422:Sequence Analysis, DNA; D056189:Viral Tropism; D054299:env Gene Products, Human Immunodeficiency Virus / Q000235:genetics
chemical_list: D012367:RNA, Viral; D015728:Receptors, HIV; D054299:env Gene Products, Human Immunodeficiency Virus